C-reactive Protein Positively Correlates With Metabolic Syndrome in Kidney Transplantation Patients

Eisenhardt, 2009, C-reactive protein: how conformational changes influence inflammatory properties, Cell Cycle, 8, 3885, 10.4161/cc.8.23.10068 Ozdemir, 2007, Serum C-reactive protein surge in renal transplant recipients: link with allograft survival, Transplant Proc, 39, 934, 10.1016/j.transproceed.2007.02.023 van Ree, 2007, Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients, Nephrol Dial Transplant, 22, 246, 10.1093/ndt/gfl511 Krüger, 2010, Is inflammation prior to renal transplantation predictive for cardiovascular and renal outcomes?, Atherosclerosis, 210, 637, 10.1016/j.atherosclerosis.2010.01.004 Winkelmayer, 2004, C-reactive protein and body mass index independently predict mortality in kidney transplant recipients, Am J Transplant, 4, 1148, 10.1111/j.1600-6143.2004.00477.x Alberti, 2006, Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation, Diabet Med, 23, 469, 10.1111/j.1464-5491.2006.01858.x Isomaa, 2001, Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes Care, 24, 683, 10.2337/diacare.24.4.683 Grundy, 2005, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 Sui, 2008, Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation, Transpl Immunol, 20, 95, 10.1016/j.trim.2008.07.003 Ward, 2009, Nutritional and metabolic issues in solid organ transplantation: targets for future research, J Ren Nutr, 19, 111, 10.1053/j.jrn.2008.10.020 de Vries, 2004, Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally, Am J Transplant, 4, 1675, 10.1111/j.1600-6143.2004.00558.x Porrini, 2006, Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation, Am J Kidney Dis, 48, 134, 10.1053/j.ajkd.2006.04.078 Courivaud, 2007, Metabolic syndrome and atherosclerotic events in renal transplant recipients, Transplantation, 83, 1577, 10.1097/01.tp.0000266898.93894.3d Hsu, 2010, Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease, Circ J, 74, 327, 10.1253/circj.CJ-09-0568 Wang, 2010, Fasting serum adiponectin level inversely correlates with metabolic syndrome in peritoneal hemodialysis patients, Blood Purif, 30, 1, 10.1159/000314647 Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation, Diabet Med, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Scott, 2003, Diagnosis, prevention, and intervention for the metabolic syndrome, Am J Cardiol, 92, 351, 10.1016/S0002-9149(03)00507-1 Naganuma, 2007, The prevalence of metabolic syndrome in Japanese renal transplant recipients, Nephrology, 12, 413, 10.1111/j.1440-1797.2007.00791.x Cheung, 2008, Prevalence of metabolic syndrome in Chinese renal transplant recipients, Hong Kong Med J, 14, 379 Volanakis, 2001, Human C-reactive protein: expression, structure, and function, Mol Immunol, 38, 189, 10.1016/S0161-5890(01)00042-6 Devaraj, 2009, Human C-reactive protein and the metabolic syndrome, Curr Opin Lipidol, 20, 182, 10.1097/MOL.0b013e32832ac03e Calabro, 2009, CRP and the risk of atherosclerotic events, Semin Immunopathol, 31, 79, 10.1007/s00281-009-0149-4 Tintera, 2004, Quantification of intra-abdominal fat during controlled weight reduction: assessment using the water-suppressed breath-hold MRI technique, Physiol Res, 53, 229, 10.33549/physiolres.930000.53.229 Lapice, 2009, Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people, Diabetes Care, 32, 1734, 10.2337/dc09-0176 Kao, 2009, Associations between body mass index and serum levels of C-reactive protein, S Afr Med J, 99, 326 Ewers, 2008, Impact of vitamin D status and obesity on C-reactive protein in kidney-transplant patients, J Ren Nutr, 18, 294, 10.1053/j.jrn.2007.11.004 van Ree, 2005, Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients, Nephrol Dial Transplant, 20, 2524, 10.1093/ndt/gfi052 Genser, 2008, Effect of HMG CoA reductase inhibitors on low-density lipoprotein cholesterol and C-reactive protein: systematic review and meta-analysis, Int J Clin Pharmacol Ther, 46, 497, 10.5414/CPP46497 Bayés, 2005, Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients, Transplant Proc, 37, 3808, 10.1016/j.transproceed.2005.08.064 Zambon, 2006, Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence, Arterioscler Thromb Vasc Biol, 26, 977, 10.1161/01.ATV.0000204327.96431.9a Consoli, 2005, Thiazolidinediones and inflammation, Lupus, 14, 794, 10.1191/0961203305lu2223oa Argani, 2008, Effects of losartan and enalapril on high-sensitivity C-reactive protein and total antioxidant in renal transplant recipients with renin-angiotensin system polymorphisms, Transplant Proc, 40, 16, 10.1016/j.transproceed.2007.11.033 Wong, 2007, Mycophenolate mofetil and C-reactive protein in renal transplant recipients, Transplantation, 83, 48, 10.1097/01.tp.0000248864.21574.92